Spread bets and CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 76% of retail investor accounts lose money when spread betting and/or trading CFDs with this provider. You should consider whether you understand how spread bets and CFDs work and whether you can afford to take the high risk of losing your money

76% of retail investor accounts lose money when spread betting and/or trading CFDs with this provider. You should consider whether you can afford to take the high risk of losing your money.

  • Updates
  • sustainable foods

Investors lose appetite for Beyond Meat and Tyson Foods shares

Having built up an appetite for fake meat products during the pandemic, investors seem to have lost their taste for Beyond Meat, while Tyson Foods' bid to be a big alternative protein player has not exactly taken off. Agronomics believes there are investment opportunities, though.

- Consumers are less willing to splash out on premium, plant-based protein products in a high-inflation environment

- Meat grown from cells is more likely to meet consumersexpectations of taste and texture

- The VanEck Future of Food ETF holds all three of Beyond Meat, Tyson Foods and Agronomics

Beyond Meat [BYND] and Tyson Foods [TSN] are feeling the impact of leaner consumer budgets, while Agronomics [ANIC.L] believes that cultivated and lab-grown meat is the future.

In the first half of 2020, many meat packing plants had to cease operating to prevent the spread of Covid-19. That combined with mass isolation led people to consider lifestyle changes, which subsequently led to a rising interest in meat alternatives.

As food prices soar and the cost-of-living eats into household incomes, people are cutting back on meat, with 28% of 1,005 UK consumers surveyed by Public First in September indicating they were already spending less on meat products. But in this instance, meat’s loss is not alternative protein’s gain.

With inflation, consumers are less willing to spend extra on a premium-priced item,” like meat substitutes, Brian Ronholm, director of food policy for Consumer Reports, told the Washington Post last week.

The Beyond Meat share price is down 77.7% year-to-date and down 4.6% in the past month. The Tyson Foods share price is down 24.2% and down 3.5% in the respective periods, while the Agronomics share price is down 45.8% and down 14.1%.

Softer demand for substitutes

Beyond Meats third-quarter (Q3) 2022 sales were down 22.5% from $106.4m in Q3 2021 to $82.5m, while its net loss increased 85.6% year-over-year from $54.8m to $101.7m.

While Tyson Foods delivered record sales and earnings for its fiscal year that ended on 1 October – it doesnt specify how its alternative protein products fared – it and Beyond Meat have both been downgraded recently by Barclays, from equal weight to underweight.

We are seeing US consumers trading down to cheaper beef and chicken cuts, with some South American buyers switching out of these proteins entirely into eggs and beans, for example… Alternative meats may be less appealing for the same reason, given affordability issues,” Benjamin Theurer, lead analyst of the research wrote in a note seen by Seeking Alpha.

Theurer also warned that the worst is yet to come'' for bottom lines in the industry. The impact is likely to be felt in 2024 and into 2025.

Cultivated meat could be the answer

Beyond Meat president, founder and CEO Ethan Brown did not sound too concerned when reporting Q3 2022 earnings in early November. The well-established history of consumers trading down among proteins” is a transitory” trend, he told analysts on the call.

While demand for plant-based protein products is currently weak, there could be long-term investment opportunities in lab-grown meat.

Agronomics, a venture capital firm, invests in startups focused on cellular agriculture – that is, cultivating meat from cells – including Dutch biotech firm Meatable. On its website, the company states its mission to satisfy the worlds appetite for meat without harming people, animals or the planet.”

Anthony Chow, co-founder of London-listed investment company Agronomics, told InvestorsChronicle in November that the problem with plant-based protein products is that they simply do not meet consumers’ sensory profile expectations”.

Nevertheless, plant-based meat’s lifecycle is not over, according to Grand View Research. The industry was worth $5.06bn in 2021 and is forecast to grow at a compound annual growth rate (CAGR) of 19.3% between 2022 and 2030.

Funds in focus: VanEck Future of Food ETF, US Vegan Climate Change ETF

The VanEck Future of Food ETF [YUMY] currently holds all three of Beyond Meat, Tyson Foods and Agronomics. As of 12 December, they have weightings of 0.63%, 1.05% and 0.35%, respectively. The fund is down 24.3% year-to-date and down 1.6% in the past month.

Beyond Meat is the seventh-biggest holding of the Global X AgTech & Food Innovation ETF [KROP], with a weighting of 4.73% as of 13 December. The fund is down 22.9% year-to-date and down 2.4% in the past month.

Beyond Meat accounts for just 0.06% of the total assets of the US Vegan Climate Change ETF [VEGN]. The fund is down 22.3% year-to-date, but up 0.8% in the past month.

Disclaimer Past performance is not a reliable indicator of future results.

CMC Markets is an execution-only service provider. The material (whether or not it states any opinions) is for general information purposes only, and does not take into account your personal circumstances or objectives. Nothing in this material is (or should be considered to be) financial, investment or other advice on which reliance should be placed. No opinion given in the material constitutes a recommendation by CMC Markets or the author that any particular investment, security, transaction or investment strategy is suitable for any specific person.

The material has not been prepared in accordance with legal requirements designed to promote the independence of investment research. Although we are not specifically prevented from dealing before providing this material, we do not seek to take advantage of the material prior to its dissemination.

CMC Markets does not endorse or offer opinion on the trading strategies used by the author. Their trading strategies do not guarantee any return and CMC Markets shall not be held responsible for any loss that you may incur, either directly or indirectly, arising from any investment based on any information contained herein.

*Tax treatment depends on individual circumstances and can change or may differ in a jurisdiction other than the UK.

Continue reading for FREE

  • Includes free newsletter updates, unsubscribe anytime. Privacy policy

Latest articles